These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29949807)

  • 1. Quantitative Criteria to Screen for Cannabis Use Disorder.
    Casajuana C; López-Pelayo H; Miquel L; Balcells-Oliveró MM; Colom J; Gual A
    Eur Addict Res; 2018; 24(3):109-117. PubMed ID: 29949807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Standard Joint Unit.
    Casajuana Kögel C; Balcells-Olivero MM; López-Pelayo H; Miquel L; Teixidó L; Colom J; Nutt DJ; Rehm J; Gual A
    Drug Alcohol Depend; 2017 Jul; 176():109-116. PubMed ID: 28531767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care.
    Matson TE; Lapham GT; Bobb JF; Oliver M; Hallgren KA; Williams EC; Bradley KA
    JAMA Netw Open; 2022 Nov; 5(11):e2239772. PubMed ID: 36318205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use.
    Myers MG; Ganoczy D; Walters HM; Pfeiffer PN; Ilgen MA; Bohnert KM
    Drug Alcohol Depend; 2023 Jun; 247():109876. PubMed ID: 37130467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians.
    Copeland WE; Hill S; Costello EJ; Shanahan L
    J Am Acad Child Adolesc Psychiatry; 2017 Feb; 56(2):124-132.e2. PubMed ID: 28117058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults.
    Gyepesi A; Urbán R; Farkas J; Kraus L; Piontek D; Paksi B; Horváth G; Magi A; Eisinger A; Pilling J; Kökönyei G; Kun B; Demetrovics Z
    Eur Addict Res; 2014; 20(3):119-28. PubMed ID: 24217457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.
    Legleye S; Piontek D; Kraus L
    Drug Alcohol Depend; 2011 Jan; 113(2-3):229-35. PubMed ID: 20869178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen of drug use: Diagnostic accuracy for cannabis use disorder.
    Tiet QQ; Leyva YE; Browne K; Moos RH
    Addict Behav; 2019 Aug; 95():184-188. PubMed ID: 30933714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students.
    Piercey CJ; Mataczynski M; Stallsmith VT; Emery NN; Karoly HC
    Cannabis Cannabinoid Res; 2024 Jun; 9(3):e917-e923. PubMed ID: 37699241
    [No Abstract]   [Full Text] [Related]  

  • 10. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
    Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study.
    Feingold D; Livne O; Rehm J; Lev-Ran S
    Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive validity of cannabis consumption measures: Results from a national longitudinal study.
    Buu A; Hu YH; Pampati S; Arterberry BJ; Lin HC
    Addict Behav; 2017 Oct; 73():36-40. PubMed ID: 28463803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of the Cannabis Abuse Screening Test (CAST) in the general population.
    Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F
    Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
    Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.
    Hjorthøj CR; Fohlmann A; Larsen AM; Arendt M; Nordentoft M
    Addiction; 2012 Jun; 107(6):1123-31. PubMed ID: 22151583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation.
    Richards DK; Schwebel FJ; Sotelo M; Pearson MR;
    Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care.
    Levy S; Weitzman ER; Marin AC; Magane KM; Wisk LE; Shrier LA
    Subst Abus; 2021; 42(3):388-395. PubMed ID: 32814009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study.
    Fond G; Picot A; Bourbon A; Boucekine M; Auquier P; Lançon C; Boyer L
    Eur Arch Psychiatry Clin Neurosci; 2021 Aug; 271(5):857-864. PubMed ID: 32372364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients.
    Legleye S; Kraus L; Piontek D; Phan O; Jouanne C
    Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.